FEMSTAT One
Company: Roche
Approval Status: Approved Februrary 1997
Treatment for: vaginal yeast infections
Areas: Obstetrics/Gynecology
Possible similar drugs: Femstat 3
General Information
Other Useful Resources
FEMSTAT One has been approved for the treatment of vulvovaginal infections caused by Candida albicans.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
